By The Numbers The Cancer Registry reports on patients who were newly diagnosed and/or received their first course of treatment for cancer progression or recurrent disease at the University of Chicago Medicine. The total number of patients seen with cancer, including all consult visits, is higher. Cancer Incidence by Type 2016 Cancer Cases by Site Primary Site Newly Diagnosed Recurrent/ Progressive Disease Total % of Total Digestive System 657 120 777 17.4% Male Genital System 559 102 661 14.8% Breast 499 70 569 12.7% Urinary System 344 83 427 9.5% Respiratory System 330 84 414 9.2% Female Genital System 251 69 320 7.1% Lymphoma 177 43 220 4.9% Oral Cavity, Larynx and Pharynx 173 24 197 4.4% Leukemia 160 32 192 4.3% Endocrine System* 156 19 175 3.9% Brain and Other Nervous System** 104 21 125 2.7% Skin (Excluding Basal and Squamous) 72 28 100 2.2% Myeloma 71 23 94 2.1% Miscellaneous*** 67 11 78 1.7% Mesothelioma 29 26 55 1.2% Soft Tissue 36 5 41 1.1% Bones and Joints 11 4 15 0.9% Eye and Orbit 1 4 5 0.1% Total 3,697 768 4,465 100% * includes benign pituitary adenomas ** includes benign neoplasms *** includes blood dyscrasias, myelodysplastic/myeloproliferative disorders and cancers with other histology/primary site designations 35